<DOC>
	<DOCNO>NCT01509547</DOCNO>
	<brief_summary>This placebo-controlled smoking cessation treatment study adolescent age 14-21 . After assessment inclusion study , participant randomize receive 12-week double blind course varenicline placebo .</brief_summary>
	<brief_title>Varenicline Adolescent Smoking Cessation</brief_title>
	<detailed_description>The objective protocol examine efficacy safety varenicline smoke cessation adolescent . The guide design philosophy model adult smoke cessation literature ( allow indirect comparison efficacy different population ) fine-tuning element specifically gear adolescent . After assessment inclusion study , participant randomize receive 12-week double blind course varenicline placebo . Participants provide smoke self-report ( cigarette per day ) throughout study . Biological confirmation carbon monoxide breathalyzer occur visit , urine cotinine measurement occur key time point ( baseline , end treatment final post-treatment follow-up ) . Psychiatric/medical visit occur weekly throughout active treatment systematically monitor safety tolerability . After 12-week treatment course , participant return 3 post-treatment follow-up visit ( Week 13 , Week 18 , Week 26 ) .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Age 1421 Daily smoker â‰¥6 month Desire quit smoking , least one prior fail quit attempt willingness participate treatment study If age 18 , parent ( ) guardian ( ) able participate inform consent initial assessment ( unless participant provide evidence emancipate status ) If female , agreement use birth control ( form hormonal contraception DepoProvera , daily oral contraception , transdermal patch , Nuvaring ; intrauterine device ; sterilization ; double barrier contraception , combination two follow method : condom , spermicide , diaphragm ) avoid pregnancy Lifetime history DSMIVTR mood psychotic disorder ( e.g. , major depressive disorder , bipolar disorder , schizophrenia ) Lifetime history suicidality , homicidality , clinically significant hostility/aggression Current substance dependence , nicotine Current unstable major medical disorder Current pregnancy breastfeed Current use medication smoke cessation efficacy Known hypersensitivity varenicline</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>